Traphagen Investment Advisors’s Fidelity MSCI Health Care Index ETF FHLC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$497K Sell
6,439
-767
-11% -$55.1K 0.04% 131
2026
Q1
$507K Sell
7,206
-2,873
-29% -$212K 0.04% 124
2025
Q4
$749K Buy
10,079
+4,610
+84% +$332K 0.06% 94
2025
Q3
$366K Sell
5,469
-2,597
-32% -$168K 0.03% 139
2025
Q2
$516K Sell
8,066
-4,433
-35% -$282K 0.05% 116
2025
Q1
$854K Sell
12,499
-9,181
-42% -$630K 0.09% 82
2024
Q4
$1.42M Sell
21,680
-6,592
-23% -$458K 0.14% 51
2024
Q3
$2.06M Sell
28,272
-8,808
-24% -$630K 0.21% 37
2024
Q2
$2.54M Sell
37,080
-28,096
-43% -$1.9M 0.28% 37
2024
Q1
$4.55M Sell
65,176
-393,072
-86% -$26.6M 0.49% 26
2023
Q4
$29.6M Sell
458,248
-21,321
-4% -$1.3M 3.48% 9
2023
Q3
$29.1M Buy
479,569
+22,835
+5% +$1.43M 3.68% 10
2023
Q2
$28.8M Buy
456,734
+5,638
+1% +$354K 3.74% 9
2023
Q1
$27.7M Sell
451,096
-317
-0.1% -$19.7K 4.08% 7
2022
Q4
$28.9M Sell
451,413
-15,084
-3% -$943K 4.54% 7
2022
Q3
$26.9M Buy
466,497
+21,143
+5% +$1.3M 4.93% 5
2022
Q2
$27M Buy
445,354
+12,811
+3% +$795K 4.92% 5
2022
Q1
$28.4M Buy
432,543
+116,056
+37% +$7.39M 4.59% 5
2021
Q4
$21.7M Buy
316,487
+15,512
+5% +$1.02M 3.56% 7
2021
Q3
$19.2M Buy
300,975
+17,833
+6% +$1.18M 3.45% 8
2021
Q2
$18M Buy
283,142
+17,603
+7% +$1.08M 3.07% 11
2021
Q1
$15.7M Buy
265,539
+51,074
+24% +$3.02M 2.87% 12
2020
Q4
$12.4M Buy
214,465
+209,652
+4,356% +$11.6M 2.23% 15
2020
Q3
$443K Sell
4,813
-199,137
-98% -$10.4M 0.09% 75
2020
Q2
$10.2M Buy
203,950
+21,205
+12% +$1.03M 2.3% 11
2020
Q1
$7.85M Buy
182,745
+42,127
+30% +$2M 2.1% 13
2019
Q4
$6.99M Buy
140,618
+4,417
+3% +$205K 1.67% 16
2019
Q3
$5.91M Buy
136,201
+5,139
+4% +$228K 1.54% 17
2019
Q2
$5.9M Buy
131,062
+11,074
+9% +$482K 1.57% 19
2019
Q1
$5.34M Buy
+119,988
New +$5.23M 1.51% 20

Other funds holding FHLC

Traphagen Investment Advisors's FHLC Position: Q2 2026 in Review

Traphagen Investment Advisors reduced its Fidelity MSCI Health Care Index ETF (FHLC) stake by 11% in Q2 2026, selling an estimated $55.1K and leaving 6,439 shares worth $497K. The position accounts for 0.04% of the portfolio, ranked #131.

Traphagen Investment Advisors first reported a position in FHLC in Q1 2019 and has held it in 30 quarters since. The position peaked at $29.6M in Q4 2023. 381 funds tracked by Wall St. Rank hold FHLC as of Q2 2026.

  • Traphagen Investment Advisors held 6,439 shares of Fidelity MSCI Health Care Index ETF worth $497K as of Q2 2026.
  • Traphagen Investment Advisors sold 767 Fidelity MSCI Health Care Index ETF shares in Q2 2026, an estimated $55.1K.
  • Fidelity MSCI Health Care Index ETF made up 0.04% of Traphagen Investment Advisors's portfolio in Q2 2026, its #131 holding.
  • Traphagen Investment Advisors first reported a position in Fidelity MSCI Health Care Index ETF in Q1 2019 and has held it in 30 quarters since.
  • Traphagen Investment Advisors's Fidelity MSCI Health Care Index ETF position peaked at $29.6M in Q4 2023.
  • 381 funds tracked by Wall St. Rank held Fidelity MSCI Health Care Index ETF as of Q2 2026.

Based on Traphagen Investment Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.